Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christopher Essers"'
Autor:
Fabian Westhauser, Maria Karadjian, Christopher Essers, Anne-Sophie Senger, Sébastien Hagmann, Gerhard Schmidmaier, Arash Moghaddam
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212799 (2019)
Since the amount of autologous bone for the treatment of bone defects is limited and harvesting might cause complications, synthetic bone substitutes such as the popular β-tricalcium phosphate (β-TCP) based Vitoss have been developed as an alternat
Externí odkaz:
https://doaj.org/article/8aeb874192dc4caaa1ca34e88d19f8bc
Autor:
Maria Karadjian, Anne-Sophie Senger, Christopher Essers, Sebastian Wilkesmann, Raban Heller, Joerg Fellenberg, Rolf Simon, Fabian Westhauser
Publikováno v:
Cells, Vol 9, Iss 4, p 918 (2020)
Fetal calf serum (FCS) is frequently used as a growth factor and protein source in bone-marrow-derived mesenchymal stromal cell (BMSC) culture media, although it is a xenogenic product presenting multiple disadvantages including but not limited to et
Externí odkaz:
https://doaj.org/article/93a327467f4f405fa125749f437940fb
Autor:
Fabian Westhauser, Christopher Essers, Maria Karadjian, Bruno Reible, Gerhard Schmidmaier, Sébastien Hagmann, Arash Moghaddam
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 17, p 4253 (2019)
Compared to other materials such as 45S5 bioactive glass (BG), β-tricalcium phosphate (β-TCP)-based bone substitutes such as Vitoss show limited material-driven stimulation of osteogenesis and/or angiogenesis. The unfavorable degradation kinetics o
Externí odkaz:
https://doaj.org/article/f1fc75ffbfb34f0daca459c611df9b22
Autor:
Maria Karadjian, Christopher Essers, Stefanos Tsitlakidis, Bruno Reible, Arash Moghaddam, Aldo R. Boccaccini, Fabian Westhauser
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 2, p 305 (2019)
Standard treatment for bone defects is the biological reconstruction using autologous bone—a therapeutical approach that suffers from limitations such as the restricted amount of bone available for harvesting and the necessity for an additional int
Externí odkaz:
https://doaj.org/article/c8c99cb35773436e83466e876ff222a0
Autor:
Christopher Essers, Fabian Westhauser, D.U. Tulyaganov, B. Widholz, Sarah I. Schmitz, Matthias Becker, I. Gonzalo de Juan, Arash Moghaddam
Publikováno v:
Bioactive Materials, Vol 5, Iss 1, Pp 55-65 (2020)
Bioactive Materials
Bioactive Materials
Bioactive glasses (BGs) are promising bone substitute materials. However, under certain circumstances BGs such as the well-known 45S5 Bioglass® (composition in wt%: 45.0 SiO2, 24.5 Na2O, 24.5 CaO, 6.0 P2O5) act cytotoxic due to a strong increase in
Autor:
Fabian Westhauser, Maria Karadjian, Christopher Essers, Anne-Sophie Senger, Sébastien Hagmann, Gerhard Schmidmaier, Arash Moghaddam
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 2, p e0212799 (2019)
PLoS ONE, Vol 14, Iss 2, p e0212799 (2019)
Since the amount of autologous bone for the treatment of bone defects is limited and harvesting might cause complications, synthetic bone substitutes such as the popular β-tricalcium phosphate (β-TCP) based Vitoss have been developed as an alternat